Award for Research Careers in Hematology
The ASH Award for Research Careers in Hematology (ARCH) succeeds the ASH Bridge Grant program, introducing refinements that include decoupling the program from the National Institutes of Health R01 funding mechanism. ARCH is now an independent award designed to make research in hematology more accessible to independent investigators.
Programmatic Priorities
To maximize the limited resources of the Society while maintaining our rigorous review process and in recognition of the challenges present in the current environment; ASH remains committed to uplifting at-risk communities within hematology, such as those engaged in addressing health outcomes for populations who experience a higher disease burden, or researchers with limited other funding opportunities. See Programmatic PrioritiesEligibility Requirements
Applicants must be a U.S. or Canadian citizen or hold a visa or permanent resident status in the US, Mexico, or Canada with plans to conduct research within the US, Mexico, or Canada. Applicants must serve as the Principal Investigator (PI) on the project, have completed residency or their terminal degree more than 13 years ago, hold a position at an academic institution or an equivalent position at a non-profit research organization, and have $500,000 or less in other resources available. See Additional Eligibility RequirementsApplication Process and Required Materials
Applicants must complete an application form and include a completed budget form with justification, NIH biographical sketch, project proposal, certification form, risk status statement, and information on other financial resources. See Additional Information on Required MaterialsEvaluation and Selection
The review of the award applications is based on the scientific merit and quality of the applicant. However, in fairness to programmatic balance, no more than two awards will be granted per medical school. Individuals selected to receive this award will be notified in the year of application, with the award commencing upon notification. At the time of the award all recipients are required to reaffirm that their ‘other resources’ remain below $500,000. See Evaluation Criteria
"I am truly grateful to ASH for this timely support, which, amid an increasingly challenging funding landscape, provides a critical lifeline to sustain the momentum and continuity of my lab’s research program."
Key Dates
| Application Available | February 2, 2026 |
| Application Deadline | March 31, 2026, at noon Eastern time |
| Award Notification | By June 30, 2026 |
| Award Activation | Upon notification |
Impact of ASH Research Funding
ARCH will continue to build on the success of its predecessor program, the ASH Bridge Grant, which was established in 2012 to help sustain critical blood research amid severe National Institutes of Health (NIH) funding restrictions.
Support
The expansion of ARCH was made possible thanks to the support of donations made to the ASH Foundation. ASH gratefully recognizes Johnson & Johnson for its support of the ASH-Johnson & Johnson ARCH recipients and Regeneron for its support of the ASH-Regeneron ARCH recipient.
Have a question
For general questions about the application contact [email protected].